Company profile
Innovative Eyewear, Inc.
NASDAQ: LUCY · Healthcare · Medical - Instruments & Supplies
#768 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
45DFH 46DQ 31GM 76SS 27
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, 3-yr revenue growth · ↓ listing tenure, Piotroski F
Methodology →Revenue TTM
$3.4M
Rev growth YoY (TTM)
+72.5%
Net income (FY)
-$7.6M
Employees
13
as of 2026-08-24
Market cap
$4.3M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.7M$2.7M2025
Net income-$7.6M-$7.6M2025
Total assets$10.1M$10.1M2025
Liabilities$1.1M$1.1M2025
Equity$9.1M$9.1M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Innovative Eyewear, Inc.’s revenue?
Innovative Eyewear, Inc. booked $2.7M in FY2025 revenue, growing 63% year over year — faster than most Healthcare companies we track, at a -285.2% net margin.
Peers · Healthcare
Absci Corporation47DHypha Labs, Inc.35DQHSLab, Inc.70BInfinity Pharmaceuticals, Inc.——ENvue Medical, Inc.46DFiore Cannabis Ltd.——Neighbors
Miami-Dade →Key facts
CEOHarrison Reed Gross
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersNorth Miami, FL
ExchangeNASDAQ: LUCY
Employees13
IPO date2022-08-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.